Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis-Reference-Cited by-同舟云学术

Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis

Published:2022-07-29 Issue:9 Volume:11 Page:1244-1255
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Moein Anita¹,Lu Tong¹^ORCID,Jönsson Siv²^ORCID,Ribbing Jakob²,Kassir Nastya¹^ORCID,Zhang Wenhui¹,Sperinde Gizette¹,Zhang Rong¹,Tang Meina¹^ORCID,Oh Young S.¹,Bruno Rene³^ORCID,Zhu Rui¹

Affiliation:

1. Genentech, Inc. South San Francisco California USA

2. Pharmetheus AB Uppsala Sweden

3. Genentech/Roche Marseille France

Funder

Genentech

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12846

Reference33 articles.

1. Long-term outcomes of colectomy surgery among patients with ulcerative colitis

2. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

4. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease

5. Ulcerative colitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of etrolizumab versus placebo in ulcerative colitis: safety and efficacy outcomes;Therapeutic Advances in Gastroenterology;2024-01

2. Research Progress in Pharmacokinetics;Journal of Advances in Physical Chemistry;2024

3. Time‐dependent clearance can confound exposure–response analysis of therapeutic antibodies: A comprehensive review of the current literature;Clinical and Translational Science;2023-11-14

4. A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score;Clinical and Translational Science;2023-09-22